Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intra-nodal injection of gentamicin for suppurated cat-scratch disease lymphadenitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gentamicin (gentamicin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Cat-Scratch Disease | Phase 3 | Status: COMPLETED